Open access
Aug 2026
The value of LAR in predicting neoadjuvant therapy response and prognosis in HER2-positive breast cancer.
BACKGROUND In the personalized treatment of HER2-positive breast cancer, identifying biomarkers predictive of neoadjuvant therapy (NAT) response and long-term prognosis is crucial. This study investigates the association between the lactate dehydrogenase-to-albumin ratio (LAR) and both NAT efficacy and survival outcome...
Xiaojing Li, Xin Xin, Wenjing Xiong et al.
· Breast Cancer · 0 citations